Therapeutic Implications of Cellular Heterogeneity and Plasticity in Breast Cancer
about
Cancer stem cell metabolismDrug Delivery Using Nanoparticles for Cancer Stem-Like Cell TargetingDistinctive properties of metastasis-initiating cellsMetabolic history impacts mammary tumor epithelial hierarchy and early drug response in mice.In vivo models in breast cancer research: progress, challenges and future directions.NADH autofluorescence, a new metabolic biomarker for cancer stem cells: Identification of Vitamin C and CAPE as natural products targeting "stemness".Cancer stem cell heterogeneity: origin and new perspectives on CSC targetingDeficiency of CCN5/WISP-2-Driven Program in breast cancer Promotes Cancer Epithelial cells to mesenchymal stem cells and Breast Cancer growth.Toward a Droplet-Based Single-Cell Radiometric AssayEpithelial/mesenchymal plasticity: how have quantitative mathematical models helped improve our understanding?Oncostatin M promotes cancer cell plasticity through cooperative STAT3-SMAD3 signaling.Cancer stem cell-driven efficacy of trastuzumab (Herceptin): towards a reclassification of clinically HER2-positive breast carcinomas.Autophagy Differentially Regulates Distinct Breast Cancer Stem-like Cells in Murine Models via EGFR/Stat3 and Tgfβ/Smad Signaling.DNA Methylation Heterogeneity Patterns in Breast Cancer Cell LinesA van der Waals-like Transition Between Normal and Cancerous Phases in Cell Populations Dynamics of Colorectal Cancer.Evaluation of Breast Cancer Stem Cells and Intratumor Stemness Heterogeneity in Triple-negative Breast Cancer as Prognostic Factors.Collagen Matrix Density Drives the Metabolic Shift in Breast Cancer Cells.TGF-β reduces DNA ds-break repair mechanisms to heighten genetic diversity and adaptability of CD44+/CD24- cancer cells.FGFR signaling maintains a drug persistent cell population following epithelial-mesenchymal transition.Microenvironmental networks promote tumor heterogeneity and enrich for metastatic cancer stem-like cells in Luminal-A breast tumor cells.A kinetic model of multiple phenotypic states for breast cancer cells.Murine melanoma cells incomplete reprogramming using non-viral vector.Antagonism of EGFR and Notch limits resistance to EGFR inhibitors and radiation by decreasing tumor-initiating cell frequency.Covalent Targeting of Fibroblast Growth Factor Receptor Inhibits Metastatic Breast Cancer.Breast cancer stem cells programs: enter the (non)-code.Oncofetal Epigenetic Bivalency in Breast Cancer Cells: H3K4 and H3K27 Tri-Methylation as a Biomarker for Phenotypic Plasticity.Tumor-Initiating Cells: Emerging Biophysical Methods of Isolation.HIF inhibitors for ischemic retinopathies and cancers: options beyond anti-VEGF therapies.Mechanisms of tumor cell resistance to the current targeted-therapy agents.Visualization and targeting of LGR5+ human colon cancer stem cells.The changing paradigm of tumour response to irradiation.Breast cancer stem cell: the roles and therapeutic implications.Oncometabolic Nuclear Reprogramming of Cancer Stemness.Hypoxia-inducible factors: coupling glucose metabolism and redox regulation with induction of the breast cancer stem cell phenotype.Breast cancer stem cells as last soldiers eluding therapeutic burn: A hard nut to crack.Metastatic breast cancer patients: attitudes toward tissue donation for rapid autopsy.Targeting hypoxic cancer stem cells (CSCs) with Doxycycline: Implications for optimizing anti-angiogenic therapy.Cell adhesion heterogeneity reinforces tumour cell dissemination: novel insights from a mathematical model.Filomicelles from aromatic diblock copolymers increase paclitaxel-induced tumor cell death and aneuploidy compared with aliphatic copolymers.Vitamin C and Doxycycline: A synthetic lethal combination therapy targeting metabolic flexibility in cancer stem cells (CSCs).
P2860
Q26746123-FBC49E43-D1EA-4E84-B524-92B184FD7DB5Q26752688-B117CB98-A8E7-4C9C-ACBB-4B8CBCA53FB2Q28069801-9D10BBC1-0B4E-481A-A476-4EAB2AEF52C2Q30390384-F1663384-0EFF-40A3-ADA0-81D1C84A4E0CQ33588117-BC6F728F-8675-4DAB-ADD4-9E7E4813EFBCQ33591293-57FE9295-06A3-4601-B7E8-901F262EE8E2Q33649230-CE31491F-CB3E-4598-A75A-DA85AA2D1C5BQ33681837-E0B0897D-76BC-492F-AACB-76896F0C6BDBQ33823931-D6AA98F3-5F0F-4DB6-9DC5-E9DCEFF37958Q33869760-79119D75-A71D-4972-92D2-BD0FA0CB80FCQ33902576-BEC48EFA-906E-4EFB-9840-E32EA5F8D732Q36544839-6EB90FF9-98C3-4310-9605-21E45D0E3A37Q37187410-BA074215-2211-4747-A6FB-274687A99005Q37275045-200414DE-E3B4-4479-AEDA-0A5D2A0A9556Q37421928-078C0F1C-6089-42AB-B7B5-554A0B3827BEQ37513954-A26502CE-2C01-4FD0-9B11-CB263DFD7F91Q37604718-7A54E845-5C26-40C6-A256-041CDD8873DCQ37693688-C61C9E72-5FD3-468D-9984-F4CC1E803252Q37696325-AB9721A4-EFB7-43A0-99B9-8BFE623AFA5CQ37697134-5D311221-1F55-443B-B869-141F8E1C8804Q38693858-55070516-D232-4566-BF3B-DD90F1905B0EQ38700249-7FBDE026-67E0-4522-8208-6E69B5BBD9F0Q38713045-EB18FAFF-5488-41CE-A114-483C30606DACQ38760333-F655B09F-5597-402E-8486-5952559DF3F4Q38765793-FC3C368B-082C-4FDE-B81F-F297FD098E85Q38790969-1780C26D-259B-4445-9A8A-3CE5AFCEB863Q38824383-3963016C-2021-4381-B745-1611BD35B5A1Q38825960-3FC11858-1A20-4500-B101-A52D435F034AQ38828353-3D6D2293-538A-4944-B5CE-CE8C7BF6B842Q38869171-E3753BC9-F886-4ADC-92B4-7FF0DB084477Q38896870-82BFA246-7105-4C8A-ADB8-FF3BA52B6BA8Q38929036-26DC6DF4-7FEF-44E1-B74B-2D563435512AQ38951334-CAE15F42-B836-46B6-BA49-359DE7EECF3EQ39051074-5ABD2C1E-D00E-4BEA-9849-4E44B1E19378Q39443694-9CB099D7-6FF5-44CA-A7CB-E672D652476BQ40170720-ADB60D08-C69D-4DDA-8C53-9025CB057DF9Q41347692-F790CE18-84AF-4F36-9BFC-6C152414E86BQ41361676-E970A8BA-6839-40E8-A2C7-49D80AD2AF93Q41453779-CB19F2D3-AE60-4413-A5FE-2F81448A0DD1Q41911837-44ABD2FD-A3BE-436A-B934-00311F10D59E
P2860
Therapeutic Implications of Cellular Heterogeneity and Plasticity in Breast Cancer
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Therapeutic Implications of Cellular Heterogeneity and Plasticity in Breast Cancer
@ast
Therapeutic Implications of Cellular Heterogeneity and Plasticity in Breast Cancer
@en
type
label
Therapeutic Implications of Cellular Heterogeneity and Plasticity in Breast Cancer
@ast
Therapeutic Implications of Cellular Heterogeneity and Plasticity in Breast Cancer
@en
prefLabel
Therapeutic Implications of Cellular Heterogeneity and Plasticity in Breast Cancer
@ast
Therapeutic Implications of Cellular Heterogeneity and Plasticity in Breast Cancer
@en
P2093
P2860
P1433
P1476
Therapeutic Implications of Cellular Heterogeneity and Plasticity in Breast Cancer
@en
P2093
Max S Wicha
Michael D Brooks
Monika L Burness
P2860
P304
P356
10.1016/J.STEM.2015.08.014
P407
P577
2015-09-01T00:00:00Z